2https://www.investors.com/news/technology/gsk-stock-jumps-after-beating-pfizer-moderna-to-the-rsv-vaccine-finish-line/ 3https://us.gsk.com/en-us/media/press-releases/us-fda-approves-gsk-s-arexvy-the-world-s-first-respiratory-syncytial-virus-rsv-vaccine-for-older-adults/ 4https://www.u...
A large new study says the RSV vaccine is 80% effective at preventing hospitalization in older adults due to complications from the illness, and works just as well at protecting them from death or needing intensive care unit support for severe complicati
CDC: RSV Vaccine Recommended for Older PeopleCENTERS for Disease Control & Prevention (U.S.)RESPIRATORY syncytial virus infection vaccinesOLDER peopledoi:10.1001/jama.2023.12537Harris, EmilyJAMA: Journal of the American Medical Association
CDC officials assured the panel that they would closely follow data from their vaccine safety systems on the launch of the two new RSV vaccines. "I want to remind everyone that we have one of the best vaccine safety systems in the world. We have the ability to rapidly acquire information, ...
RSV vaccines are available. Three RSV vaccines have been approved for older adults by the U.S. Food and Drug Administration. You only need a single dose that you can get at any time of the year, but getting the vaccine in the early fall offers the best protection for the late fall and...
The US Food and Drug Administration on Friday approved Moderna's respiratory syncytial virus (RSV) vaccine for older adults—marking the first time any mRNA shot has been authorized against a disease other than COVID-19.
They also recommended vaccination for adults aged 60 to 74 years with risk factors for severe RSV. The CDC’s vaccine advisors voted unanimously Wednesday to recommend that everyone aged 75 years or older get vaccinated against respiratory syncytial virus. ...
GSK used a priority review voucher to speed its age extension application through the FDA approval process. The agency is currently reviewing an application from Pfizer to extend the license for its RSV vaccine, Abrysvo, to include adults 18 and older who have health conditions that put them at...
Originally, Arexvy was the only FDA-approved RSV vaccine for older adults. However, since this approval, two other RSV vaccines have come to market. The Pfizer RSV vaccine, Abrysvo, is also a protein subunit vaccine. The CDC estimates the effectiveness of protein subunit RSV ...
6、https://us.gsk.com/en-us/media/press-releases/us-fda-approves-gsk-s-arexvy-the-world-s-first-respiratory-syncytial-virus-rsv-vaccine-for-older-adults/#_ftnref1 7、https://www.usatoday.com/story/news/health/2023/05/03/f...